This episode transcript covers:
  • Alessio’s lab’s ground-breaking research into protein degradation,
  • The opening of the University of Dundee’s new Centre for Targeted Protein Degradation (CeTPD)
  • The opportunities and challenges of novel degrader design.

To listen to this full podcast episode, click here.

Find out more

 

This insight and data is part of the subscription to Beacon TPD.

Beacon TPD Logo

 

Find out more

Speak with our Team

Our dedicated Sales and Research teams can help you with questions by showing you how this insight and data is collated on Beacon

Bertie MacArthur  

 

Request a Demo

About Beacon Targeted Therapies

We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.

 

Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements

Find out more

logo
Verified by MonsterInsights